| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Materials Department, Physics Department, and Biomolecular Science and Engineering Program, University of California, Santa Barbara, California
Correspondence: Address reprint requests to C. R. Safinya, MRL Rm. 2208, University of California, Santa Barbara, CA 93106. Tel.: 805-893-8635; Fax: 805-893-7221; E-mail: safinya{at}mrl.ucsb.edu.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The mixing of cationic liposomes and DNA results in their spontaneous self-assembly into 0.2-µm size particles of CL-DNA complexes. The driving force for this is the large increase in entropy resulting from the release of tightly bound counterions from the cationic lipid membranes and the anionic DNA rods. In the lamellar CL-DNA complexes, the DNA monolayers, sandwiched between lipid bilayers, are ordered with a well-defined separation distance between adjacent DNA rods (Koltover et al., 2000
; Rädler et al., 1997
). We show that by tuning different parameters of the lipid membrane, in particular with the introduction of PEG-lipids, we can adjust this DNA distance between 25 Å and 60 Å.
The structure, morphology, and function of PEG-CL-DNA complexes were characterized using x-ray diffraction, optical microscopy, and reporter gene assays, respectively. X-ray diffraction probed the inner structure of the complex, in particular the incorporation of the polymer into the inside of the complex, whereas optical microscopy and reporter gene assays allowed us to investigate the surface functionalization achieved by PEGylation of the complexes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-phage DNA (48,502 bp), purchased from New England Biolabs (Beverly, MA), was used. For microscopy and transfection experiments, plasmid DNA containing the luciferase gene was used (pGL3-Control vector, Promega, Madison, WI). DOTAP (1,2-dioleoyl-3-trimethyl-ammonium-propane, molecular weight 698.55) and the neutral "helper" lipid DOPC (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine, 786.13 mol wt) were purchased from Avanti Polar Lipids (Alabaster, AL). A novel set of PEG-lipids, some of which incorporate two charged amino groups at the end of the polymeric chain, was synthesized according to the procedure previously described (Schulze et al., 1999
n
= 9, 1394 mol wt) and PEG20002+-lipid (
n
= 45, 3010 mol wt) were investigated. These were compared with similar neutral PEG-lipids, PEG400-lipid (
n
= 9, 1035 mol wt) and PEG2000-lipid (
n
= 45, 2635 mol wt). The chemical structures of these molecules are shown in Fig. 1. Microscopy and transfection experiments were done with PEG2000-lipid (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)-2000]) (
n
= 45, 2802 mol wt), purchased from Avanti Polar Lipids.
|
X-ray diffraction
PEG-CL-DNA complexes were prepared by mixing 50100 µg of
-phage DNA at 5 mg/ml with liposome mixtures at 25 mg/ml in an Eppendorf centrifuge for
3 h. Samples were prepared at the isoelectric (charge neutral) point. After three days of storage at 4°C to allow the samples to reach equilibrium, the samples were transferred to 1.5-mm diameter quartz x-ray capillaries.
The high-resolution x-ray diffraction experiments were carried out at the Stanford Synchrotron Radiation Laboratory at an x-ray energy of 10 KeV using a double bounce Si (111) crystal. Powder diffraction measurements were taken with a PMT Bicron detector (Paris, France).
Optical microscopy
PEG-CL-DNA complexes were prepared by mixing 2 µg of pGL3 plasmid DNA at 0.1 mg/ml, fluorescently tagged with YOYO dye purchased from Molecular Probes, with Texas Red DHPE labeled PEG-CLs at 0.5 mg/ml. Samples were prepared in Dulbecco's modified Eagle's medium (DMEM; Gibco, Gaithersburg, MD) at a charge ratio of 2.8 to mimic the conditions of in vitro experiments. Differential interference contrast and fluorescence images were taken with a Nikon Diaphot 300 microscope (Nikon, Tokyo, Japan) and imaged with a QE Sensicam (Cooke, Auburn Hills, MI).
Cell transfection
Mouse fibroblast L-cells were cultured in DMEM supplemented with 1% (v/v) penicillin-streptomycin (Gibco BRL) and 5% (v/v) Fetal Bovine Serum (Gibco BRL) at 37°C in a 5% CO2 atmosphere, splitting the cells every 24 days to maintain monolayer coverage. The cells were transfected at a confluency of 6080% in six well plates (35 mm diameter per well). Using liposome (0.5 mg/ml) and DNA (1 mg/ml) stock solutions, liposome and DNA stocks were further diluted in DMEM to a final volume of 0.5 ml and complexes, containing 2 µg of pGL3-DNA, were prepared at a cationic/anionic charge ratio of 2.8. The cells were incubated with complexes for 6 h, rinsed 3 times with PBS (Phosphate Buffered Saline, Gibco BRL), and incubated in supplemented DMEM for an additional 24 h (sufficient for a complete cell cycle) to allow expression of the luciferase gene. Luciferase gene expression was measured with the Luciferase Assay System from Promega and light output readings were performed on a Berthold AutoLumat luminometer (Wallac, Gaithersburg, MD). Transfection efficiency was normalized to milligrams of total cellular protein using the Bio-Rad Protein Assay Dye Reagent (Bio-Rad, Hercules, CA) and is expressed as relative light units per mg of total cellular protein.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
/q001 = 68.3 Å, that corresponds to the membrane thickness (
m) plus water gap (
w) between the lipid bilayer. The broader peak at qDNA, marked with an arrow, arises from the 2D smectic ordering of the DNA rods, separated by a distance dDNA = 2
/qDNA = 47.6 Å. The second order of the DNA-DNA correlation peak is also visible (DNA II). The dotted line in Fig. 2 corresponds to the position of the DNA peak for the sample without PEG-lipid.
|
6%). Figs. 2, C and D, show the effect of incorporating neutral PEG400-lipid and PEG2000-lipid. In the case of PEG400-lipid we see that the DNA-spacing remains constant, within error, compared to the reference sample without PEG-lipid, whereas PEG2000-lipid behaves similar to PEG20002+-lipid. We examine this behavior below. Fig. 3 shows the variation of the distance between DNA chains with increasing molar fraction of PEG4002+-lipid at fixed MDOTAP. Different symbols correspond to different values of MDOTAP. The series at lower MDOTAP show a large decrease in dDNA as a function of increasing molar fraction of PEG4002+-lipid, indicating a significant compaction of the DNA rods. For higher MDOTAP almost no variation is observed (Fig. 3 A).
|
M, of the lipid bilayer. This parameter was calculated taking into account the contribution of charge from both DOTAP and the cationic PEG-lipid,
M = e(1NDOTAP + 2NPEG-lipid)/(ADOTAPNDOTAP + ADOPCNDOPC + APEG-lipidNPEG-lipid). Assuming that the headgroup size is the same for all lipids (Alipid = 72 Å (Gruner et al., 1988
M = e(MDOTAP + 2MPEG-lipid)/Alipid. The solid circles, corresponding to dDNA for the reference system complexes (no PEG-lipids), show a perfect agreement with predicted dDNA values, represented by the continuous line. These predicted values were obtained for isoelectric complexes, taking into account only electrostatic interactions and geometric contributions. Complex formation, driven by counterion release, dictates that the DNA chains should occupy all the available membrane area while matching the charges of the cationic lipids. As reported earlier (Koltover et al., 1999
![]() |
DNA = 1.7 g/cm3 and
lipid = 1.07 g/cm3 are the densities of lipid and DNA respectively; ADNA is the cross section area of a DNA molecule,
iso = 2.2 is the weight ratio of DOTAP and DNA for stoichiometrically charge neutral complexes, and
DOPC is the weight fraction of DOPC.
The experimental values for dDNA collected in Fig. 3 B reveal the existence of two distinct DNA interaction regimes for CL-DNA complexes with short cationic PEG-lipids (PEG4002+-lipid). For 0.27 < MDOTAP < 0.43 and 0 < MPEG4002+-lipid < 9%, the results show very good agreement with the dDNA predicted values. This defines the electrostatic regime, where dDNA depends purely on the membrane charge density (
M) for a complex at the isoelectric point. For MDOTAP > 0.53 a strong repulsive hydration barrier (Salditt et al., 1998
) between DNA rods becomes relevant, making it impossible to further condense the DNA by adding PEG4002+-lipid.
These results indicate that PEG4002+-lipid is acting as a cationic colipid, leading to condensation of DNA through an increase in the membrane charge density. As mentioned earlier, the inset in Fig. 3 B, comparing the addition of cationic PEG4002+-lipid with neutral PEG400-lipid, shows that condensation only occurs when cationic PEG-lipid is used. This suggests that the PEG chain length of PEG4002+-lipid (
n
= 9) is too short to show any polymeric behavior, even in a 2D system. Instead, repulsive electrostatics and hydration forces dominate the system as found in the reference system without PEG-lipids (Salditt et al., 1998
). We can further conclude that PEG4002+-lipid completely incorporates into the CL-DNA complexes since it forms one phase even at high amounts of PEG4002+-lipid (MPEG4002+-lipid = 30%). Finally, we conclude that the condensation of DNA by different lipid systems forming lamellar complexes follows a universal charge-condensation curve in the electrostatic regime (dDNA > 31 Å) (Lin et al., 2003
).
We now examine the influence of a PEG-lipid with a longer polymer chain. Fig. 4 A shows the variation of the distance between DNA chains in single-phase PEG-CL-DNA complexes upon adding PEG20002+-lipid for various series of fixed MDOTAP. These results seem similar to those obtained with PEG4002+-lipid, but when plotted as a function of membrane charge density, significant differences become apparent.
|
Unlike for the short-chain PEG, the inset in Fig. 4 B shows that for PEG2000-lipid, the cationic and the neutral lipid both yield the same result. The DNA spacing, plotted for MDOTAP = 0.33, decreases with increasing MPEG20002+-lipid and MPEG2000-lipid. These results show that the polymer chain-DNA interaction dominates in this system, as opposed to electrostatics as seen in the case of PEG4002+-lipid and PEG400-lipid. The data also confirms that the depletion attraction force is indeed responsible for the additional DNA condensation with increasing amounts of MPEG20002+-lipid, even at remarkably low concentrations of PEG-lipid (MPEG20002+-lipid < 1%).
The depletion attraction phenomenon (Vroege and Lekkerkerker, 1992
) in our system is analogous to the polymer-induced condensation of DNA solutions (Vasilevskaya et al., 1995
). In our experiments, we find that when PEG2000-lipid is incorporated within the CL-DNA complexes, it induces a depletion attraction force between the DNA rods adsorbed on the cationic membranes because the DNA has a depletion region around it, which excludes the PEG2000 part of the PEG-lipid molecule (Fig. 5 A). This depletion attraction force causes a phase separation between the polymer and the DNA rods within the layers inside the complex as shown schematically in Fig. 5 B. The complex has DNA-rich domains, shown in green, and polymer-rich domains, shown in blue (Fig. 5 C). Our predicted values of dDNA, from the universal charge-condensation curve, dictate a water gap between DNA rods of 535 Å to accommodate the added polymer. As PEG2000 has an Rg of 35 Å (Devanand and Selser, 1991
; Warriner et al., 1996
), we should expect PEG2000-lipid to be excluded from regions between DNA rods (Israelachvili, 1992
). Thus, the closer DNA spacing observed in our data is a result of the osmotic stress exerted on the DNA domains due to the PEG2000 chains. This is the 2D analog of what happens in 3D solutions of DNA containing the polymer PEG where depletion attraction induces bundling of DNA with the polymer PEG being excluded from the bundle region. Again, the polymer PEG is known to exert an osmotic stress on the bundle phase, which increases as the concentration of polymer is increased, and leads to the DNA interaxial spacing decreasing.
|
To investigate the incorporation and behavior of PEG-lipids on the surface of CL-DNA complexes, we used optical microscopy as well as established transfection protocols. All of these experiments were conducted in DMEM, a biologically relevant cell culturing medium containing
150 mM monovalent salt, at a charge ratio of +2.8 (leading to positively charged complexes).
Optical microscopy at MDOTAP = 0.82 confirms the existence of complexes through colocalization of DNA and lipid and further demonstrates the different behavior of the complexes depending on polymer chain length. Fig. 6 A shows complexes without PEG-lipid. Some degree of aggregation of the complexes is observed, due to the presence of DMEM. Fig. 6 B shows a complex at MPEG400-lipid = 10%. Again the aggregation of the complexes is clearly evident. Only for complexes prepared using the longer polymer lipid at MPEG2000-lipid = 10% do we see an effect of the PEG-lipid. No aggregation of complex particles is observed due to steric repulsion conferred by a shell of PEG2000-lipid polymer chains even in the presence of salt. This shows that the PEG-lipid is coating the surfaces of the complexes, whereas x-ray diffraction results clearly demonstrate that the PEG-lipid is located internally, as well. As mentioned earlier, this polymeric stabilization is important for developing a viable in vivo gene delivery system (Allen, 1994
; Harvie et al., 2000
; Pitard et al., 2001
; Wheeler et al., 1999
).
|
M and high
M, respectively. We investigated the effect of added PEG-lipid in both of these regimes.
|
M, as evident from the x-ray data (Fig. 3, inset). By contrast, a decrease in the already low efficiency occurs with the addition of long-chain PEG-lipids (PEG2000-lipid), regardless of the presence of cationic charges on the PEG-lipid. At 2% added PEG2000-lipid, TE is less affected by the cationic lipid, but at 6% PEG-lipid, the effects of the neutral and charged PEG2000-lipid are similar. A fraction of the PEG2000-lipid is most likely coating the outside of the CL-DNA complexes, thus shielding cell-complex interaction and subsequent transfection. Our data indicates that PEG coverage of the CL-DNA complexes occurs with 6% PEG2000-lipid. Data points were not taken beyond 10% in anticipation of phase separation between CL-DNA complexes and the PEG2000-lipids. In direct contrast, the CL-DNA complexes can accommodate up to 20% PEG400-lipid without phase separation, but there is no indication that shielding occurs with these shorter amphiphiles.
The long-chain PEG-lipids show a similar behavior in the high TE regime at MDOTAP = 0.80 (Fig. 7 B). Transfection efficiency is high without added PEG-lipid but decreases nearly two orders of magnitude upon addition of 6% PEG2000-lipid, either cationic or neutral. The addition of cationic PEG4002+-lipid in this case does not lead to higher efficiency; in fact, both cationic and neutral PEG400-lipid behave similarly, only negligibly affecting TE. In this high initial
M regime, TE already is at a maximum and further addition of cationic colipid does not aid transfection (Lin et al., 2003
).
These results are promising and point to future experiments. The transfection data, in combination with optical microscopy, proves that PEG2000 is coating the CL-DNA complexes. A cell-specific targeting component, i.e., a peptide sequence such as RGD, could be tethered to the PEG2000 molecules to promote specific attachment to cells while retaining sterically stabilized PEG2000-CL-DNA complexes.
| CONCLUSIONS |
|---|
|
|
|---|
Furthermore, for the first time we have shown the existence of three distinct interaction regimes within the lamellar structure of the CL-DNA complexes, where repulsive long-range electrostatic forces, short-range repulsive hydration forces, and polymer-induced attractive depletion forces dominate the interaction between DNA molecules. By tuning certain parameters, such as the polymer length and the membrane charge density, we can access any of these regimes.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Submitted on June 19, 2003; accepted for publication October 14, 2003.
| REFERENCES |
|---|
|
|
|---|
Bradley, A. J., D. V. Devine, S. M. Ansell, J. Janzen, and D. E. Brooks. 1998. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol) lipids. Arch. Biochem. Biophys. 357:185194.[Medline]
Bruinsma, R., and J. Mashl. 1998. Long-range electrostatic interaction in DNA cationic lipid complexes. Europhys. Lett. 41:165170.
Chesnoy, S., and L. Huang. 2000. Structure and function of lipid-DNA complexes for gene delivery. Annu. Rev. Biophys. Biomol. Struct. 29:2747.[Medline]
Devanand, K., and J. C. Selser. 1991. Asymptotic behavior and long-range interactions in aqueous solutions of poly(ethylene oxide). Macromolecules. 24:59435947.
Ewert, K., A. Ahmad, H. M. Evans, H. W. Schmidt, and C. R. Safinya. 2002. Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. J. Med. Chem. 45:50235029.[Medline]
Felgner, P. L. 1997. Nonviral strategies for gene therapy. Sci. Am. 276:102106.[Medline]
Felgner, P. L., and G. Rhodes. 1991. Gene therapeutics. Nature. 349:351352.[Medline]
Gruner, S. M., M. W. Tate, G. L. Kirk, P. T. C. So, D. C. Turner, D. T. Keane, C. P. S. Tilcock, and P. R. Cullis. 1988. X-ray diffraction study of the polymorphic behavior of N-methylated dioleoylphosphatidylethanolamine. Biochemistry. 27:28532866.[Medline]
Harries, D., S. May, W. M. Gelbart, and A. Ben-Shaul. 1998. Structure, stability, and thermodynamics of lamellar DNA-lipid complexes. Biophys. J. 75:159173.
Harris, J. M., and S. Zalipsky, editors. 1997. Poly(ethylene glycol) Chemistry and Biological Applications. American Chemical Society, Washington, DC.
Harvie, P., F. M. P. Wong, and M. B. Bally. 2000. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J. Pharm. Sci. 89:652663.[Medline]
Israelachvili, J. 1992. Intermolecular and Surface Forces. Academic Press, London.
Koltover, I., T. Salditt, J. O. Rädler, and C. R. Safinya. 1998. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science. 281:7881.
Koltover, I., T. Salditt, and C. R. Safinya. 1999. Phase Diagram, Stability, and Overcharging of Lamellar Cationic Lipid-DNA Self-Assembled Complexes. Biophys. J. 77:915924.
Koltover, I., K. Wagner, and C. R. Safinya. 2000. DNA condensation in two dimensions. Proc. Natl. Acad. Sci. USA. 97:1404614051.
Lasic, D. D., and F. J. Martin, editors. 1995a. Stealth Liposomes. CRC Press, Boca Raton, FL.
Lasic, D. D., and D. Papahadjopoulos. 1995b. Liposomes revisited. Science. 267:12751276.
Lasic, D. D., H. Strey, M. C. A. Stuart, R. Podgornik, and P. M. Frederik. 1997. The structure of DNA-liposome complexes. J. Am. Chem. Soc. 119:832833.
Lin, A. J., N. L. Slack, A. Ahmad, C. X. George, C. E. Samuel, and C. R. Safinya. 2003. Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. Biophys. J. 84:33073316.
Lin, A. J., N. L. Slack, A. Ahmad, I. Koltover, C. X. George, C. E. Samuel, and C. R. Safinya. 2000. Structure and structure-function studies of lipid/plasmid DNA complexes. J. Drug Target. 8:1327.[Medline]
Mahato, R. I., and S. W. Kim, editors. 2002. Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics. Taylor & Francis, London.
Midoux, P., and C. Pichon. 2002. Peptide-based gene delivery systems. In Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics. S. W. Kim, editor. Taylor & Francis, London. 334366.
Mislick, K. A., and J. D. Baldeschwieler. 1996. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 93:1234912354.
Pitard, B., N. Oudrhiri, O. Lambert, E. Vivien, C. Masson, B. Wetzer, M. Hauchecorne, D. Scherman, J. L. Rigaud, J. P. Vigneron, J. M. Lehn, and P. Lehn. 2001. Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo. J. Gene Med. 3:478487.[Medline]
Rädler, J. O., I. Koltover, T. Salditt, and C. R. Safinya. 1997. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science. 275:810814.
Safinya, C. R. 2001. Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr. Opin. Struct. Biol. 11:440448.[Medline]
Salditt, T., I. Koltover, O. Radler, and C. R. Safinya. 1998. Self-assembled DNA-cationic-lipid complexes: Two-dimensional smectic ordering, correlations, and interactions. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 58:889904.
Schulze, U., H. W. Schmidt, and C. R. Safinya. 1999. Synthesis of novel cationic poly(ethylene glycol) containing lipids. Bioconjug. Chem. 10:548552.[Medline]
Suh, W., S. O. Han, L. Yu, and S. W. Kim. 2002. An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol. Ther. 6:664672.[Medline]
Tristram-Nagle, S., H. I. Petrache, and J. F. Nagle. 1998. Structure and interactions of fully hydrated dioleoylphosphatidylcholine bilayers. Biophys. J. 75:917925.
Vasilevskaya, V. V., A. R. Khokhlov, Y. Matsuzawa, and K. Yoshikawa. 1995. Collapse of single DNA molecule in poly(ethylene glycol) solutions. J. Chem. Phys. 102:65956602.
Vroege, G. J., and H. N. W. Lekkerkerker. 1992. Phase transitions in lyotropic colloidal and polymer liquid crystals. Rep. Prog. Phys. 55:12411309.
Warriner, H. E., S. H. J. Idziak, N. L. Slack, P. Davidson, and C. R. Safinya. 1996. Lamellar biogels: fluid-membrane-based hydrogels containing polymer lipids. Science. 271:969973.[Abstract]
Wheeler, J. J., L. Palmer, M. Ossanlou, I. MacLachlan, R. W. Graham, Y. P. Zhang, M. J. Hope, P. Scherrer, and P. R. Cullis. 1999. Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. 6:271281.[Medline]
Woodle, M. C. 1995. Sterically stabilized liposome therapeutics. Adv. Drug Deliv. Rev. 16:249265.
Woodle, M. C., P. Scaria, S. Ganesh, K. Subramanian, R. Titmas, C. Cheng, J. Yang, Y. Pan, K. Weng, C. Gu, and S. Torkelson. 2001. Sterically stabilized polyplex: ligand-mediated activity. J. Control. Release. 74:309311.[Medline]
Zalipsky, S. 1995. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjug. Chem. 6:150165.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |